Denne side blev automatisk oversat, og nøjagtigheden af ​​oversættelsen er ikke garanteret. Der henvises til engelsk version for en kildetekst.

Video laryngeal maske vs. endotracheal rør i septoplastik

12. november 2026 opdateret af: Samsun University

Sammenligning af video -laryngeal maske luftvej og endotracheal rørbrug til luftvejssikkerhed hos patienter, der gennemgår septoplastik

This study compares two devices used to help adults breathe during general anesthesia for septoplasty, an operation to straighten the wall between the two sides of the nose. The study is conducted at one hospital and includes adults aged 18-65 years.

The main question is whether the amount of blood found in the airway at the end of surgery differs between the two devices. Researchers also compare breathing measurements, heart rate and blood pressure, device placement, recovery from anesthesia, surgeon satisfaction, and throat symptoms after surgery.

Participants receive either a SaCoVLM™ video laryngeal mask, which sits above the opening of the windpipe and has a built-in camera, or a conventional breathing tube placed inside the windpipe. The devices are assigned in a fixed alternating order, rather than by chance.

At the end of surgery, researchers check for blood inside the windpipe using a thin, flexible camera in both groups. They also assess blood near the opening of the windpipe using methods specific to each device.

Sore throat, difficulty swallowing, cough, and hoarseness are assessed in the recovery unit and at 2, 8, 12, 24, and 48 hours after surgery.

Studieoversigt

Detaljeret beskrivelse

This single-center, prospective, non-randomized, interventional study compares the SaCoVLM™ video laryngeal mask airway (VLMA) with a conventional endotracheal tube (ETT) in adults aged 18-65 years with American Society of Anesthesiologists (ASA) physical status I-II undergoing elective septoplasty under general anesthesia.

Consecutive eligible patients are assigned to the ETT and VLMA groups in a predetermined alternating sequence. Allocation is systematic rather than random, and no random sequence generator is used.

Anesthetic Management

Standard monitoring includes electrocardiography, noninvasive blood pressure, peripheral oxygen saturation, end-tidal carbon dioxide, and bispectral index monitoring. Anesthesia is induced with intravenous fentanyl and propofol and maintained with sevoflurane and remifentanil.

Volume-controlled ventilation is delivered with a tidal volume of 6-8 mL/kg, a respiratory rate of 12 breaths/min, a positive end-expiratory pressure of 5 cmH2O, and an inspiratory-to-expiratory ratio of 1:2.

Hemodynamic and respiratory measurements are obtained, as applicable, at baseline, after anesthesia induction immediately before airway device placement, at 1, 3, 5, 10, 15, and 30 minutes after placement, and 5 minutes after device removal.

Airway Blood Contamination

The primary outcome is airway blood contamination at the end of surgery, graded on a four-point scale: 1 = no blood, 2 = mild contamination, 3 = moderate contamination, and 4 = severe contamination.

In the VLMA group, proximal glottic blood contamination is assessed directly through the device's integrated camera. In the ETT group, proximal contamination is assessed indirectly by inspecting blood around the tube cuff after careful aspiration of the posterior oropharynx and extubation. These assessments are device-specific and do not represent anatomically equivalent measurements.

Distal tracheal blood contamination is assessed by flexible bronchoscopy in both groups, regardless of the proximal findings.

Additional Assessments

Secondary outcomes include hemodynamic responses, ventilation parameters, airway device insertion time, number of placement attempts, ease of placement, ventilation leakage, peak airway pressure, glottic visualization, surgeon satisfaction, and early postoperative recovery.

Recovery is assessed using recovery time and the Modified Aldrete Score. Postoperative sore throat, dysphagia, cough, and hoarseness are assessed in the post-anesthesia care unit and at 2, 8, 12, 24, and 48 hours after surgery.

Undersøgelsestype

Interventionel

Tilmelding (Faktiske)

70

Fase

  • Ikke anvendelig

Kontakter og lokationer

Dette afsnit indeholder kontaktoplysninger for dem, der udfører undersøgelsen, og oplysninger om, hvor denne undersøgelse udføres.

Studiesteder

    • Ilkadim
      • Samsun, Ilkadim, Tyrkiet (Türkiye), 55000
        • Samsun University, Samsun Training and Research Hospital

Deltagelseskriterier

Forskere leder efter personer, der passer til en bestemt beskrivelse, kaldet berettigelseskriterier. Nogle eksempler på disse kriterier er en persons generelle helbredstilstand eller tidligere behandlinger.

Berettigelseskriterier

Aldre berettiget til at studere

18 år til 65 år (Voksen, Ældre voksen)

Tager imod sunde frivillige

Ingen

Køn, der er berettiget til at studere

Alle

Beskrivelse

Inclusion Criteria:

  • Patients aged 18-65 years
  • ASA physical status I-II
  • Patients scheduled for elective septoplasty under general anesthesia

Exclusion Criteria:

  • Anticipated difficult airway
  • ASA physical status III-IV
  • History of gastroesophageal reflux disease or hiatal hernia
  • Body mass index greater than 30 kg/m²
  • Pregnancy

Studieplan

Dette afsnit indeholder detaljer om studieplanen, herunder hvordan undersøgelsen er designet, og hvad undersøgelsen måler.

Hvordan er undersøgelsen tilrettelagt?

Design detaljer

  • Primært formål: Støttende pleje
  • Tildeling: Ikke-randomiseret
  • Interventionel model: Parallel tildeling
  • Maskning: Ingen (Åben etiket)

Våben og indgreb

Deltagergruppe / Arm
Intervention / Behandling
Eksperimentel: VLMA Group

Thirty-five patients were allocated to airway management using the SaCoVLM™ video laryngeal mask airway (VLMA) according to a predetermined alternating allocation sequence. Three patients experienced ventilation-related difficulties and were excluded from the final comparative analysis. The remaining 32 patients were analyzed. Proximal glottic blood contamination was assessed using the integrated camera, and distal tracheal blood contamination was evaluated using flexible bronchoscopy in all 32 analyzed patients.

The SaCoVLM™ video laryngeal mask airway, a supraglottic airway device with an integrated camera, was used for airway management during elective septoplasty. The integrated camera enabled direct visualization of the glottic inlet and assessment of proximal blood contamination. At the end of surgery, distal tracheal blood contamination was assessed using flexible bronchoscopy in all 32 VLMA patients included in the final analysis, regardless of proximal blood contamination findings. Airway insertion characteristics, ventilation and hemodynamic parameters, recovery outcomes, and postoperative airway morbidity were recorded.

Aktiv komparator: ETT Group

Thirty-five patients were allocated to airway management using a conventional cuffed endotracheal tube (ETT) according to a predetermined alternating allocation sequence. Three patients were excluded from the final comparative analysis because surgical duration exceeded 90 minutes. The remaining 32 patients were analyzed. Proximal blood contamination was assessed by examining blood around the ETT cuff after oropharyngeal aspiration and extubation. Distal tracheal blood contamination was evaluated using flexible bronchoscopy in all 32 analyzed patients.

A conventional cuffed endotracheal tube was inserted using direct laryngoscopy for airway management during elective septoplasty. At the end of surgery, the distal trachea was examined for blood contamination using flexible bronchoscopy through the ETT before removal. Proximal tracheal/glottic contamination was assessed indirectly by examining blood around the distal portion of the ETT cuff after aspiration of the posterior oropharynx and extubation. Airway insertion characteristics, ventilation and hemodynamic parameters, recovery outcomes, and postoperative airway morbidity were recorded.

Hvad måler undersøgelsen?

Primære resultatmål

Resultatmål
Foranstaltningsbeskrivelse
Tidsramme
Airway Blood Contamination at the End of Surgery
Tidsramme: At the end of surgery, immediately before and/or after airway device removal, depending on the assessment method.

Airway blood contamination was assessed at the end of surgery at two anatomical levels: proximal glottic/tracheal and distal tracheal regions.

Contamination was graded using a four-point ordinal scale: 1 = no blood, 2 = mild contamination, 3 = moderate contamination, and 4 = severe contamination. Higher scores indicated greater blood contamination.

In the VLMA group, proximal glottic blood contamination was assessed directly using the integrated camera. In the ETT group, proximal blood contamination was assessed indirectly by examining blood around the endotracheal tube cuff following oropharyngeal aspiration and extubation. These assessment methods were device-specific and anatomically non-equivalent.

Distal tracheal blood contamination was assessed using flexible bronchoscopy in all 64 patients included in the final analysis (32 patients per group), regardless of proximal contamination findings.

Contamination scores were recorded separately for the proximal and distal regions. N

At the end of surgery, immediately before and/or after airway device removal, depending on the assessment method.

Sekundære resultatmål

Resultatmål
Foranstaltningsbeskrivelse
Tidsramme
Heart Rate (HR)
Tidsramme: From preoperative baseline to 5 minutes after airway device removal.

Heart rate, measured in beats per minute, was recorded at preoperative baseline; after anesthesia induction immediately before airway device placement; at 1, 3, 5, 10, 15, and 30 minutes after successful airway device placement; and at 5 minutes after airway device removal.

From preoperative baseline to 5 minutes after airway device removal.
Postoperative Sore Throat (POST Score)
Tidsramme: From PACU recovery through 48 hours postoperatively (PACU, 2, 8, 12, 24, and 48 hours).

Postoperative sore throat was assessed by direct patient questioning using a four-point ordinal scale: 0 = no sore throat; 1 = cold-like sensation or minimal discomfort; 2 = mild-to-moderate pain during swallowing; and 3 = continuous pain without swallowing.

Assessments were scheduled during post-anesthesia care unit recovery and at 2, 8, 12, 24, and 48 hours postoperatively. Between-group comparative analyses were performed through 12 hours. Findings at 24 and 48 hours were summarized descriptively using available symptom scores. Discharge entries and blank symptom scores were considered missing data. Missing scores were not imputed.

From PACU recovery through 48 hours postoperatively (PACU, 2, 8, 12, 24, and 48 hours).
Arterial Blood Pressure
Tidsramme: From preoperative baseline to 5 minutes after airway device removal.

Systolic, diastolic, and mean arterial blood pressures, measured in mmHg, were recorded at preoperative baseline; after anesthesia induction immediately before airway device placement; at 1, 3, 5, 10, 15, and 30 minutes after successful airway device placement; and at 5 minutes after airway device removal.

From preoperative baseline to 5 minutes after airway device removal.
Airway Insertion Time
Tidsramme: Assessed once during airway device placement, immediately after anesthesia induction.

Airway insertion time was recorded in seconds. In the ETT group, it was defined as the time from the start of the intubation attempt until three consecutive regular end-tidal carbon dioxide waveforms were observed on capnography. In the VLMA group, it was defined as the time from picking up the device until three consecutive regular end-tidal carbon dioxide waveforms were observed on capnography.

Assessed once during airway device placement, immediately after anesthesia induction.
Intraoperative and Early Postoperative Airway Complications
Tidsramme: From anesthesia induction through the early postoperative period in the post-anesthesia care unit.

The occurrence of laryngospasm and bronchospasm was assessed through clinical observation during the intraoperative and early postoperative periods. Each complication was recorded separately as present or absent.

From anesthesia induction through the early postoperative period in the post-anesthesia care unit.
Postoperative Dysphagia
Tidsramme: From PACU recovery through 48 hours postoperatively (PACU, 2, 8, 12, 24, and 48 hours).

Postoperative dysphagia was assessed by direct patient questioning using a four-point ordinal scale: 0 = no swallowing difficulty; 1 = minimal discomfort during swallowing; 2 = mild-to-moderate difficulty during swallowing; and 3 = marked swallowing difficulty.

Assessments were scheduled during post-anesthesia care unit (PACU) recovery and at 2, 8, 12, 24, and 48 hours postoperatively. Between-group comparative analyses were restricted to assessments through 12 hours. Findings at 24 and 48 hours were summarized descriptively using available symptom scores. Discharge entries and blank symptom scores were classified as missing data. Missing scores were not imputed.

From PACU recovery through 48 hours postoperatively (PACU, 2, 8, 12, 24, and 48 hours).
First-Attempt Success Rate of Airway Device Insertion
Tidsramme: Assessed once during airway device placement immediately after anesthesia induction.

First-attempt success was recorded separately for each airway device as successful or unsuccessful. The total number of placement attempts required to achieve successful airway placement was also recorded. Successful placement was confirmed by three consecutive regular end-tidal carbon dioxide waveforms.

Assessed once during airway device placement immediately after anesthesia induction.
Postoperative Cough
Tidsramme: From PACU recovery through 48 hours postoperatively (PACU, 2, 8, 12, 24, and 48 hours).

Postoperative cough was assessed using a four-point ordinal scale: 0 = no cough; 1 = mild cough; 2 = moderate cough; and 3 = severe cough.

For statistical analysis, cough scores were categorized as absent (score 0) or present (scores 1-3). Results were expressed as the number and percentage of patients with cough in each group.

Assessments were scheduled during post-anesthesia care unit (PACU) recovery and at 2, 8, 12, 24, and 48 hours postoperatively. Between-group comparative analyses were restricted to assessments through 12 hours. Findings at 24 and 48 hours were summarized descriptively using available symptom scores. Discharge entries and blank symptom scores were classified as missing data. Missing scores were not imputed.

From PACU recovery through 48 hours postoperatively (PACU, 2, 8, 12, 24, and 48 hours).
Postoperative Hoarseness
Tidsramme: From PACU recovery through 48 hours postoperatively (PACU, 2, 8, 12, 24, and 48 hours).

Postoperative hoarseness was assessed using a four-point scale: 0 = no hoarseness; 1 = mild voice changes; 2 = moderate voice changes; and 3 = marked hoarseness.

For statistical analysis, scores were categorized as absent (0) or present (1-3). Results were expressed as the number and percentage of patients with hoarseness in each group.

Assessments were scheduled during post-anesthesia care unit (PACU) recovery and at 2, 8, 12, 24, and 48 hours postoperatively. Between-group comparative analyses were restricted to assessments through 12 hours. Findings at 24 and 48 hours were summarized descriptively using available symptom scores. Discharge entries and blank symptom scores were classified as missing data. Missing scores were not imputed.

From PACU recovery through 48 hours postoperatively (PACU, 2, 8, 12, 24, and 48 hours).
Surgeon Satisfaction With Surgical Conditions
Tidsramme: At the end of surgery (single assessment).

Surgeon satisfaction with surgical conditions was assessed at the end of surgery using a four-point ordinal scale: 0 = very good, 1 = good, 2 = poor, and 3 = very poor (surgical conditions unsuitable for initiating the procedure). Lower scores indicated greater satisfaction. Results were expressed as the number and percentage of patients in each category for both groups.

At the end of surgery (single assessment).

Samarbejdspartnere og efterforskere

Det er her, du vil finde personer og organisationer, der er involveret i denne undersøgelse.

Efterforskere

  • Studieleder: Hatice Selcuk KUSDERCI, M.D., Samsun University

Publikationer og nyttige links

Den person, der er ansvarlig for at indtaste oplysninger om undersøgelsen, leverer frivilligt disse publikationer. Disse kan handle om alt relateret til undersøgelsen.

Datoer for undersøgelser

Disse datoer sporer fremskridtene for indsendelser af undersøgelsesrekord og resumeresultater til ClinicalTrials.gov. Studieregistreringer og rapporterede resultater gennemgås af National Library of Medicine (NLM) for at sikre, at de opfylder specifikke kvalitetskontrolstandarder, før de offentliggøres på den offentlige hjemmeside.

Studer store datoer

Studiestart (Faktiske)

30. april 2025

Primær færdiggørelse (Faktiske)

3. november 2025

Studieafslutning (Faktiske)

4. november 2025

Datoer for studieregistrering

Først indsendt

24. marts 2025

Først indsendt, der opfyldte QC-kriterier

27. april 2025

Først opslået (Faktiske)

30. april 2025

Opdateringer af undersøgelsesjournaler

Sidste opdatering sendt (Faktiske)

18. november 2026

Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier

12. november 2026

Sidst verificeret

1. november 2026

Mere information

Begreber relateret til denne undersøgelse

Plan for individuelle deltagerdata (IPD)

Planlægger du at dele individuelle deltagerdata (IPD)?

UBESLUTET

Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter

Studerer et amerikansk FDA-reguleret lægemiddelprodukt

Ingen

Studerer et amerikansk FDA-reguleret enhedsprodukt

Ingen

Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .

Abonner